Original Research

Review of presentations and radiotherapy outcomes of patients with malignant spinal cord compression

Louisa M. Mbokazi, Sheynaz Bassa, Krishanthavathie Pillay
South African Journal of Oncology | Vol 9 | a305 | DOI: https://doi.org/10.4102/sajo.v9i0.305 | © 2025 Louisa M. Mbokazi, Sheynaz Bassa, Krishanthavathie Pillay | This work is licensed under CC Attribution 4.0
Submitted: 26 April 2024 | Published: 13 January 2025

About the author(s)

Louisa M. Mbokazi, Department of Radiation Oncology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
Sheynaz Bassa, Department of Radiation Oncology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
Krishanthavathie Pillay, Department of Radiation Oncology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa

Abstract

Background: Malignant spinal cord compression (MSCC) is the commonest radiotherapy emergency. A high index of suspicion, prompt diagnosis, early referral and treatment is important to restore quality of life and improve survival in patients with MSCC.

Aim: This study aimed to evaluate the clinical and treatment characteristics of patients presenting with MSCC at the Radiation Oncology department.

Setting: The study was conducted at Steve Biko Academic Hospital, Radiation Oncology.

Methods: This is a retrospective review of 110 patients who were treated for MSCC between January 2022 and November 2023. Information on patients’ characteristics, disease characteristics, imaging findings, radiotherapy dose prescription, clinical response and survival was extracted from clinical records.

Results: Breast and prostate cancer were the most frequent primary disease sites. Most patients presented in a poor Eastern Cooperative Oncology Group (ECOG) performance status (PS 4), de novo disease (63%) and multilevel vertebral involvement (70%). Eighty-four patients (76.4%) received a single fraction treatment (6 Gy – 8 Gy). The median overall survival was 145 days. Patients with a Rades score of 32–37 points had a statistically significant better overall survival at 1 year compared with those with a score of 22–31 points. There was no difference in survival between single versus multiple fraction treatment.

Conclusion: A single fraction radiotherapy schedule is acceptable in this setting where most patients present with extensive disease and non-ambulatory baseline function.

Contribution: The findings from this study could be used to establish protocols for treatment strategies in facilities with limited resources.


Keywords

radiotherapy; malignant spinal cord compression; palliative; treatment outcomes; dose fractionation

Sustainable Development Goal

Goal 3: Good health and well-being

Metrics

Total abstract views: 183
Total article views: 124


Crossref Citations

No related citations found.